Description

SUSTEN 100 MG

Indications

SUSTEN 100 MG is primarily indicated for hormone replacement therapy in women experiencing menopause-related symptoms, such as hot flashes and vaginal dryness. It is also utilized in the treatment of conditions associated with progesterone deficiency, including amenorrhea and abnormal uterine bleeding. Additionally, SUSTEN is prescribed to support pregnancy in women undergoing assisted reproductive technology (ART) and to prevent premature labor in certain high-risk patients.

Mechanism of Action

SUSTEN contains the active ingredient micronized progesterone, a natural form of the hormone progesterone. Its mechanism of action involves the regulation of various physiological processes in the body. In the menstrual cycle, progesterone prepares the endometrium for potential implantation of a fertilized egg. In cases of hormone replacement therapy, SUSTEN counteracts the effects of estrogen on the endometrium, thereby reducing the risk of endometrial hyperplasia. This balance is crucial for maintaining reproductive health and supporting pregnancy.

Pharmacological Properties

The pharmacokinetics of SUSTEN demonstrate that micronized progesterone is rapidly absorbed, with peak plasma concentrations typically reached within 2 to 4 hours after administration. The bioavailability of oral progesterone is approximately 10-15%, which is significantly enhanced when the drug is administered via the vaginal route. SUSTEN is extensively metabolized in the liver, primarily through the cytochrome P450 system, and its metabolites are excreted mainly in urine. The elimination half-life of progesterone is approximately 5 to 20 hours, depending on the route of administration.

Contraindications

SUSTEN should not be used in individuals with a known hypersensitivity to progesterone or any of the excipients in the formulation. It is contraindicated in patients with active or history of thromboembolic disorders, such as deep vein thrombosis or pulmonary embolism. Additionally, SUSTEN is not recommended for use in individuals with liver dysfunction, undiagnosed vaginal bleeding, or hormone-sensitive cancers, including breast cancer.

Side Effects

Common side effects associated with SUSTEN include dizziness, headache, breast tenderness, and gastrointestinal disturbances such as nausea and bloating. Some patients may experience mood changes, fatigue, or changes in libido. Serious side effects, although rare, can include thromboembolic events, liver dysfunction, and allergic reactions. Patients should be advised to report any unusual symptoms or side effects to their healthcare provider promptly.

Dosage and Administration

The recommended dosage of SUSTEN 100 MG varies based on the indication for use. For hormone replacement therapy, the typical dosage is 100 mg to 200 mg daily, taken at bedtime. In cases of amenorrhea or abnormal uterine bleeding, the dosage may be adjusted according to the clinician’s discretion. For patients undergoing ART, SUSTEN is usually administered starting from the day of embryo transfer until the 12th week of gestation. It is essential to follow the healthcare provider’s instructions regarding dosage and administration to ensure optimal therapeutic outcomes.

Interactions

SUSTEN may interact with other medications, potentially altering its effectiveness or increasing the risk of side effects. Drugs that induce or inhibit cytochrome P450 enzymes can significantly affect the metabolism of progesterone. Additionally, the concurrent use of anticoagulants may require careful monitoring due to the potential for increased thromboembolic risk. Patients should inform their healthcare provider about all medications, supplements, and herbal products they are taking to avoid possible interactions.

Precautions

Before initiating treatment with SUSTEN, a thorough medical history should be obtained, and a physical examination should be conducted. Special caution should be exercised in patients with a history of cardiovascular disease, hypertension, diabetes, or seizure disorders. Regular monitoring of blood pressure, liver function, and overall health is recommended during treatment. Women who are pregnant or breastfeeding should discuss the risks and benefits of SUSTEN with their healthcare provider before use.

Clinical Studies

Clinical studies have demonstrated the efficacy of SUSTEN in managing menopausal symptoms and supporting early pregnancy. In a randomized controlled trial, women receiving SUSTEN reported significant improvements in hot flashes and overall quality of life compared to those receiving a placebo. Another study highlighted the role of SUSTEN in improving pregnancy outcomes in women undergoing ART, showing higher rates of successful implantation and reduced miscarriage rates. These findings underscore the therapeutic potential of SUSTEN in various clinical settings.

Conclusion

SUSTEN 100 MG is a valuable therapeutic option for women requiring progesterone supplementation, whether for hormone replacement therapy or in the context of pregnancy support. Its natural formulation, coupled with a well-established safety profile, makes it a preferred choice among healthcare providers. However, as with any medication, it is crucial for patients to use SUSTEN responsibly and under the guidance of a qualified healthcare professional to ensure optimal outcomes and minimize risks.